Y Intercept (Hong Kong) LTD Ocugen, Inc. Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.5 - $1.83 $64,412 - $235,749	128,825 New	128,825 $211,000
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.88 $36,135 - $70,664	-80,300 Reduced 36.21%	141,491 $76,000
Q1 2023 May 09, 2023	BUY	$0.82 - $1.33 $181,868 - $294,982	221,791 New	221,791 $188,000
Q4 2022 Feb 14, 2023	SELL	$1.11 - $1.87 $37,781 - $63,649	-34,037 Closed	0 $0
Q3 2022 Feb 14, 2023	BUY	$1.75 - $3.1 $59,564 - $105,514	34,037 New	34,037 $60,000

125

78.4M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $158M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.